Sign Up
Stories
Boston Scientific's Q4 Results Exceed Expectations
Share
BMY Stock's Undervaluation
Biogen's Q3 Report and Reata Acquisition
BlackBerry's Loss and Business Separatio...
Allstate Surpasses Q1 Earnings Forecast
Altria Affirms 2024 Earnings Outlook
Analysts Cut Forecasts on CoStar Group
Overview
API
Boston Scientific's Q4 results exceed expectations with adjusted EPS of 55 cents and net sales reaching $3.73 billion. All divisions experienced strong performance, aligning with estimates.
Ask a question
How does Boston Scientific's Q4 results compare to its previous performance?
What are the implications of Boston Scientific's Q4 results for the medical devices industry?
What factors contributed to the strong performance of all divisions?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Jan 2024
Coverage